JP3146508B2 - Optically active compound and method for producing the same - Google Patents
Optically active compound and method for producing the sameInfo
- Publication number
- JP3146508B2 JP3146508B2 JP09296291A JP9296291A JP3146508B2 JP 3146508 B2 JP3146508 B2 JP 3146508B2 JP 09296291 A JP09296291 A JP 09296291A JP 9296291 A JP9296291 A JP 9296291A JP 3146508 B2 JP3146508 B2 JP 3146508B2
- Authority
- JP
- Japan
- Prior art keywords
- optically active
- general formula
- phenyl
- pyrimidine
- hydroxyphenyl
- Prior art date
- Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
- Expired - Fee Related
Links
- 150000001875 compounds Chemical class 0.000 title claims description 35
- 238000004519 manufacturing process Methods 0.000 title claims description 5
- -1 fatty acid ester Chemical class 0.000 claims description 16
- 235000014113 dietary fatty acids Nutrition 0.000 claims description 6
- 239000000194 fatty acid Substances 0.000 claims description 6
- 229930195729 fatty acid Natural products 0.000 claims description 6
- YCCILVSKPBXVIP-UHFFFAOYSA-N 2-(4-hydroxyphenyl)ethanol Chemical compound OCCC1=CC=C(O)C=C1 YCCILVSKPBXVIP-UHFFFAOYSA-N 0.000 claims description 4
- 238000005886 esterification reaction Methods 0.000 claims description 4
- 230000032050 esterification Effects 0.000 claims 2
- LFQSCWFLJHTTHZ-UHFFFAOYSA-N Ethanol Chemical compound CCO LFQSCWFLJHTTHZ-UHFFFAOYSA-N 0.000 description 18
- ZMXDDKWLCZADIW-UHFFFAOYSA-N N,N-Dimethylformamide Chemical compound CN(C)C=O ZMXDDKWLCZADIW-UHFFFAOYSA-N 0.000 description 18
- 239000000203 mixture Substances 0.000 description 16
- QTBSBXVTEAMEQO-UHFFFAOYSA-N Acetic acid Chemical compound CC(O)=O QTBSBXVTEAMEQO-UHFFFAOYSA-N 0.000 description 15
- CZPWVGJYEJSRLH-UHFFFAOYSA-N Pyrimidine Chemical compound C1=CN=CN=C1 CZPWVGJYEJSRLH-UHFFFAOYSA-N 0.000 description 14
- 125000001997 phenyl group Chemical group [H]C1=C([H])C([H])=C(*)C([H])=C1[H] 0.000 description 14
- 125000001495 ethyl group Chemical group [H]C([H])([H])C([H])([H])* 0.000 description 12
- 125000004464 hydroxyphenyl group Chemical group 0.000 description 12
- XLYOFNOQVPJJNP-UHFFFAOYSA-N water Substances O XLYOFNOQVPJJNP-UHFFFAOYSA-N 0.000 description 9
- 150000002148 esters Chemical class 0.000 description 8
- XHXFXVLFKHQFAL-UHFFFAOYSA-N phosphoryl trichloride Chemical compound ClP(Cl)(Cl)=O XHXFXVLFKHQFAL-UHFFFAOYSA-N 0.000 description 8
- 239000000126 substance Substances 0.000 description 8
- FYSNRJHAOHDILO-UHFFFAOYSA-N thionyl chloride Chemical compound ClS(Cl)=O FYSNRJHAOHDILO-UHFFFAOYSA-N 0.000 description 8
- 239000005262 ferroelectric liquid crystals (FLCs) Substances 0.000 description 7
- 238000000034 method Methods 0.000 description 7
- WFDIJRYMOXRFFG-UHFFFAOYSA-N Acetic anhydride Chemical compound CC(=O)OC(C)=O WFDIJRYMOXRFFG-UHFFFAOYSA-N 0.000 description 6
- KWYUFKZDYYNOTN-UHFFFAOYSA-M Potassium hydroxide Chemical compound [OH-].[K+] KWYUFKZDYYNOTN-UHFFFAOYSA-M 0.000 description 6
- JUJWROOIHBZHMG-UHFFFAOYSA-N Pyridine Chemical compound C1=CC=NC=C1 JUJWROOIHBZHMG-UHFFFAOYSA-N 0.000 description 6
- 238000006243 chemical reaction Methods 0.000 description 6
- 239000004973 liquid crystal related substance Substances 0.000 description 6
- 230000015572 biosynthetic process Effects 0.000 description 5
- 238000001914 filtration Methods 0.000 description 5
- 239000002244 precipitate Substances 0.000 description 5
- 238000003786 synthesis reaction Methods 0.000 description 5
- NGNBDVOYPDDBFK-UHFFFAOYSA-N 2-[2,4-di(pentan-2-yl)phenoxy]acetyl chloride Chemical compound CCCC(C)C1=CC=C(OCC(Cl)=O)C(C(C)CCC)=C1 NGNBDVOYPDDBFK-UHFFFAOYSA-N 0.000 description 4
- CSCPPACGZOOCGX-UHFFFAOYSA-N Acetone Chemical compound CC(C)=O CSCPPACGZOOCGX-UHFFFAOYSA-N 0.000 description 4
- HEDRZPFGACZZDS-UHFFFAOYSA-N Chloroform Chemical compound ClC(Cl)Cl HEDRZPFGACZZDS-UHFFFAOYSA-N 0.000 description 4
- RTZKZFJDLAIYFH-UHFFFAOYSA-N Diethyl ether Chemical compound CCOCC RTZKZFJDLAIYFH-UHFFFAOYSA-N 0.000 description 4
- VEXZGXHMUGYJMC-UHFFFAOYSA-N Hydrochloric acid Chemical compound Cl VEXZGXHMUGYJMC-UHFFFAOYSA-N 0.000 description 4
- MPCRDALPQLDDFX-UHFFFAOYSA-L Magnesium perchlorate Chemical compound [Mg+2].[O-]Cl(=O)(=O)=O.[O-]Cl(=O)(=O)=O MPCRDALPQLDDFX-UHFFFAOYSA-L 0.000 description 4
- CSNNHWWHGAXBCP-UHFFFAOYSA-L Magnesium sulfate Chemical compound [Mg+2].[O-][S+2]([O-])([O-])[O-] CSNNHWWHGAXBCP-UHFFFAOYSA-L 0.000 description 4
- CDBYLPFSWZWCQE-UHFFFAOYSA-L Sodium Carbonate Chemical compound [Na+].[Na+].[O-]C([O-])=O CDBYLPFSWZWCQE-UHFFFAOYSA-L 0.000 description 4
- YQLMHXJICJZZFV-UHFFFAOYSA-N [amino-(4-ethoxycarbonylphenyl)methylidene]azanium;chloride Chemical compound [Cl-].CCOC(=O)C1=CC=C(C([NH3+])=N)C=C1 YQLMHXJICJZZFV-UHFFFAOYSA-N 0.000 description 4
- 238000004458 analytical method Methods 0.000 description 4
- 239000007864 aqueous solution Substances 0.000 description 4
- WGQKYBSKWIADBV-UHFFFAOYSA-N benzylamine Chemical compound NCC1=CC=CC=C1 WGQKYBSKWIADBV-UHFFFAOYSA-N 0.000 description 4
- 125000002887 hydroxy group Chemical group [H]O* 0.000 description 4
- 238000000655 nuclear magnetic resonance spectrum Methods 0.000 description 4
- 239000011541 reaction mixture Substances 0.000 description 4
- UMJSCPRVCHMLSP-UHFFFAOYSA-N pyridine Natural products COC1=CC=CN=C1 UMJSCPRVCHMLSP-UHFFFAOYSA-N 0.000 description 3
- 238000010992 reflux Methods 0.000 description 3
- 238000005406 washing Methods 0.000 description 3
- 238000005160 1H NMR spectroscopy Methods 0.000 description 2
- PMRFBLQVGJNGLU-UHFFFAOYSA-N 4-(1-hydroxyethyl)phenol Chemical compound CC(O)C1=CC=C(O)C=C1 PMRFBLQVGJNGLU-UHFFFAOYSA-N 0.000 description 2
- PMRFBLQVGJNGLU-LURJTMIESA-N 4-[(1s)-1-hydroxyethyl]phenol Chemical compound C[C@H](O)C1=CC=C(O)C=C1 PMRFBLQVGJNGLU-LURJTMIESA-N 0.000 description 2
- NRPFNQUDKRYCNX-UHFFFAOYSA-N 4-methoxyphenylacetic acid Chemical compound COC1=CC=C(CC(O)=O)C=C1 NRPFNQUDKRYCNX-UHFFFAOYSA-N 0.000 description 2
- ANEAPXSTNOCXJW-UHFFFAOYSA-N CCOC(=O)C1=CC=C(C=C1)C2=NC=C(C=N2)C3=CC=CC=C3OC Chemical compound CCOC(=O)C1=CC=C(C=C1)C2=NC=C(C=N2)C3=CC=CC=C3OC ANEAPXSTNOCXJW-UHFFFAOYSA-N 0.000 description 2
- RXXGBBKFGRJHPG-UHFFFAOYSA-N CCOC(=O)C1=CC=C(C=C1)C2=NC=C(C=N2)C3=CC=CC=C3OCC4=CC=CC=C4 Chemical compound CCOC(=O)C1=CC=C(C=C1)C2=NC=C(C=N2)C3=CC=CC=C3OCC4=CC=CC=C4 RXXGBBKFGRJHPG-UHFFFAOYSA-N 0.000 description 2
- CPELXLSAUQHCOX-UHFFFAOYSA-N Hydrogen bromide Chemical compound Br CPELXLSAUQHCOX-UHFFFAOYSA-N 0.000 description 2
- WYURNTSHIVDZCO-UHFFFAOYSA-N Tetrahydrofuran Chemical compound C1CCOC1 WYURNTSHIVDZCO-UHFFFAOYSA-N 0.000 description 2
- 125000002777 acetyl group Chemical group [H]C([H])([H])C(*)=O 0.000 description 2
- 150000001656 butanoic acid esters Chemical class 0.000 description 2
- 239000013078 crystal Substances 0.000 description 2
- GHVNFZFCNZKVNT-UHFFFAOYSA-N decanoic acid Chemical compound CCCCCCCCCC(O)=O GHVNFZFCNZKVNT-UHFFFAOYSA-N 0.000 description 2
- 150000001954 decanoic acid esters Chemical class 0.000 description 2
- 238000010511 deprotection reaction Methods 0.000 description 2
- 230000000694 effects Effects 0.000 description 2
- 229910052943 magnesium sulfate Inorganic materials 0.000 description 2
- 235000019341 magnesium sulphate Nutrition 0.000 description 2
- 239000012044 organic layer Substances 0.000 description 2
- VLTRZXGMWDSKGL-UHFFFAOYSA-M perchlorate Inorganic materials [O-]Cl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-M 0.000 description 2
- VLTRZXGMWDSKGL-UHFFFAOYSA-N perchloric acid Chemical compound OCl(=O)(=O)=O VLTRZXGMWDSKGL-UHFFFAOYSA-N 0.000 description 2
- 230000000704 physical effect Effects 0.000 description 2
- 150000003839 salts Chemical class 0.000 description 2
- 229920006395 saturated elastomer Polymers 0.000 description 2
- 238000010898 silica gel chromatography Methods 0.000 description 2
- 229910000029 sodium carbonate Inorganic materials 0.000 description 2
- QDRKDTQENPPHOJ-UHFFFAOYSA-N sodium ethoxide Chemical compound [Na+].CC[O-] QDRKDTQENPPHOJ-UHFFFAOYSA-N 0.000 description 2
- 239000000243 solution Substances 0.000 description 2
- NAWXUBYGYWOOIX-SFHVURJKSA-N (2s)-2-[[4-[2-(2,4-diaminoquinazolin-6-yl)ethyl]benzoyl]amino]-4-methylidenepentanedioic acid Chemical compound C1=CC2=NC(N)=NC(N)=C2C=C1CCC1=CC=C(C(=O)N[C@@H](CC(=C)C(O)=O)C(O)=O)C=C1 NAWXUBYGYWOOIX-SFHVURJKSA-N 0.000 description 1
- VZDCGVORAWCHEG-UHFFFAOYSA-N 1-[4-(1-ethoxyethoxy)phenyl]ethanol Chemical compound CCOC(C)OC1=CC=C(C(C)O)C=C1 VZDCGVORAWCHEG-UHFFFAOYSA-N 0.000 description 1
- KPWDGTGXUYRARH-UHFFFAOYSA-N 2,2,2-trichloroethanol Chemical compound OCC(Cl)(Cl)Cl KPWDGTGXUYRARH-UHFFFAOYSA-N 0.000 description 1
- XJHGAJLIKDAOPE-UHFFFAOYSA-N 2-(4-phenylmethoxyphenyl)acetic acid Chemical compound C1=CC(CC(=O)O)=CC=C1OCC1=CC=CC=C1 XJHGAJLIKDAOPE-UHFFFAOYSA-N 0.000 description 1
- SEGJDCGIQJESDC-UHFFFAOYSA-N 2-methylbutyl 3-phenylprop-2-enoate Chemical compound CCC(C)COC(=O)C=CC1=CC=CC=C1 SEGJDCGIQJESDC-UHFFFAOYSA-N 0.000 description 1
- BMYNFMYTOJXKLE-UHFFFAOYSA-N 3-azaniumyl-2-hydroxypropanoate Chemical compound NCC(O)C(O)=O BMYNFMYTOJXKLE-UHFFFAOYSA-N 0.000 description 1
- 239000004986 Cholesteric liquid crystals (ChLC) Substances 0.000 description 1
- 108090000790 Enzymes Proteins 0.000 description 1
- 102000004190 Enzymes Human genes 0.000 description 1
- 108090000371 Esterases Proteins 0.000 description 1
- UFHFLCQGNIYNRP-UHFFFAOYSA-N Hydrogen Chemical compound [H][H] UFHFLCQGNIYNRP-UHFFFAOYSA-N 0.000 description 1
- 239000004988 Nematic liquid crystal Substances 0.000 description 1
- KDLHZDBZIXYQEI-UHFFFAOYSA-N Palladium Chemical compound [Pd] KDLHZDBZIXYQEI-UHFFFAOYSA-N 0.000 description 1
- 239000004990 Smectic liquid crystal Substances 0.000 description 1
- 125000004432 carbon atom Chemical group C* 0.000 description 1
- 238000009903 catalytic hydrogenation reaction Methods 0.000 description 1
- 238000001035 drying Methods 0.000 description 1
- ZYAYIXIILWJKSN-UHFFFAOYSA-N ethyl 4-pyrimidin-2-ylbenzoate Chemical compound C1=CC(C(=O)OCC)=CC=C1C1=NC=CC=N1 ZYAYIXIILWJKSN-UHFFFAOYSA-N 0.000 description 1
- 230000001747 exhibiting effect Effects 0.000 description 1
- 150000004665 fatty acids Chemical class 0.000 description 1
- 230000005621 ferroelectricity Effects 0.000 description 1
- 229910052739 hydrogen Inorganic materials 0.000 description 1
- 239000001257 hydrogen Substances 0.000 description 1
- 125000004435 hydrogen atom Chemical group [H]* 0.000 description 1
- 229910000042 hydrogen bromide Inorganic materials 0.000 description 1
- 239000005457 ice water Substances 0.000 description 1
- 239000000463 material Substances 0.000 description 1
- UKVIEHSSVKSQBA-UHFFFAOYSA-N methane;palladium Chemical compound C.[Pd] UKVIEHSSVKSQBA-UHFFFAOYSA-N 0.000 description 1
- 125000002496 methyl group Chemical group [H]C([H])([H])* 0.000 description 1
- 239000003960 organic solvent Substances 0.000 description 1
- 125000006239 protecting group Chemical group 0.000 description 1
- YLQBMQCUIZJEEH-UHFFFAOYSA-N tetrahydrofuran Natural products C=1C=COC=1 YLQBMQCUIZJEEH-UHFFFAOYSA-N 0.000 description 1
- 239000010409 thin film Substances 0.000 description 1
- 238000005809 transesterification reaction Methods 0.000 description 1
- 230000007704 transition Effects 0.000 description 1
- 229920001567 vinyl ester resin Polymers 0.000 description 1
Landscapes
- Organic Low-Molecular-Weight Compounds And Preparation Thereof (AREA)
- Liquid Crystal Substances (AREA)
Description
【0001】[0001]
【産業上の利用分野】本発明は新規な光学活性化合物及
びその製造方法に関する。更に詳しくは、液晶組成物、
とくに強誘電性液晶組成物を製造するために使用される
中間体として有用な、新規な光学活性エステル誘導体及
びその製造方法に関する。The present invention relates to a novel optically active compound and a method for producing the same. More specifically, a liquid crystal composition,
In particular, the present invention relates to a novel optically active ester derivative useful as an intermediate used for producing a ferroelectric liquid crystal composition and a method for producing the same.
【0002】[0002]
【従来の技術】液晶化合物が電気光学表示装置に利用さ
れて以来、数多くの液晶化合物が合成され、ネマチック
液晶またはネマチック−コレステリック液晶が、STN
型表示素子、ネマチック−コレステリック相転移型表示
素子またはゲスト−ホスト効果利用表示素子等に広く利
用されている。これらの表示素子の応答速度は最高でも
数msecオーダーであるために液晶表示素子の応答範
囲には限界があるとされていた。しかし、近年では強誘
電性液晶を用いた場合にはμsecオーダーの高速応答
が得られることがわかってきた。2. Description of the Related Art Since liquid crystal compounds have been used in electro-optical display devices, a large number of liquid crystal compounds have been synthesized, and nematic liquid crystals or nematic-cholesteric liquid crystals have been produced using STN.
It is widely used for a display device of the type, a nematic-cholesteric phase transition type display device, a display device utilizing the guest-host effect, and the like. Since the response speed of these display elements is at most on the order of several milliseconds, it has been considered that the response range of the liquid crystal display element is limited. However, in recent years, it has been found that when a ferroelectric liquid crystal is used, a high-speed response on the order of μsec can be obtained.
【0003】従来、知られている強誘電性液晶の例とし
ては、1975年にR.B.Meyer等によって合成
された4−(4−n−デシルオキシベンジリデンアミ
ノ)ケイ皮酸−2−メチルブチルエステル(以下、DO
BAMBC)があげられる。この物質はそのカイラルス
メクチックC相に於いて強誘電性を示すことを特徴とし
ている[J.Physique.,36,69(197
5)]。また、1980年には、N.A.Clark等
がDOBAMBCを使用した薄膜セルに於いてμsec
オーダーの高速応答が得られることを見出している[A
ppl.Phys.Let.,36,89(198
0)]。[0003] In 1975, an example of a conventionally known ferroelectric liquid crystal is disclosed in R.A. B. 4- (4-n-decyloxybenzylideneamino) cinnamic acid-2-methylbutyl ester synthesized by Meyer et al.
BAMBC). This material is characterized by exhibiting ferroelectricity in its chiral smectic C phase [J. Physique. , 36 , 69 (197
5)]. Also, in 1980, N. A. Clark et al. In a thin film cell using DOBAMBC
A high-speed response of the order can be obtained [A
ppl. Phys. Let. , 36 , 89 (198
0)].
【0004】しかし、その後、多くの強誘電性液晶の合
成研究がなされてきたにもかかわらず、物性的要求の全
てを単一化合物で満たす強誘電性液晶化合物は未だ見出
されておらず、全ての物性的要求を満たすためには何種
類かの強誘電性液晶化合物を組み合わせた組成物を用い
なければならない現状である。[0004] However, despite the fact that many studies on the synthesis of ferroelectric liquid crystals have been made, no ferroelectric liquid crystal compound satisfying all the physical properties with a single compound has been found yet. At present, it is necessary to use a composition combining several types of ferroelectric liquid crystal compounds in order to satisfy all physical properties.
【0005】[0005]
【発明が解決しようとしている課題】本発明は、このよ
うな要求を満たす液晶組成物を製造するために使用され
る中間体として有用な、新規な光学活性エステル誘導体
を提供することであり、更に他の一つは該エステル誘導
体を安易に製造し得る方法を提供することにある。SUMMARY OF THE INVENTION An object of the present invention is to provide a novel optically active ester derivative which is useful as an intermediate used for producing a liquid crystal composition satisfying such requirements. Another object is to provide a method for easily producing the ester derivative.
【0006】[0006]
【課題を解決する手段】本発明は、一般式(1):According to the present invention, there is provided a compound represented by the following general formula (1):
【0007】[0007]
【化1】Embedded image
【0008】で表される光学活性化合物、および一般式
(2):An optically active compound represented by the general formula (2):
【0009】[0009]
【化2】Embedded image
【0010】で表される光学活性化合物、並びに一般式
(3):An optically active compound represented by the general formula (3):
【0011】[0011]
【化3】Embedded image
【0012】で表される化合物を、一般式(4):A compound represented by the general formula (4):
【0013】[0013]
【化4】Embedded image
【0014】で表されるp−ヒドロキシフェニルエタノ
ールの脂肪酸エステルによりエステル化した後、脱アセ
トキシ化することを特徴とする上記光学活性化合物の製
造方法に関する。[0014] The present invention relates to a method for producing the above-mentioned optically active compound, which comprises esterifying with a fatty acid ester of p-hydroxyphenylethanol represented by the formula (1), followed by deacetoxylation.
【0015】以下に本発明を詳細に説明する。Hereinafter, the present invention will be described in detail.
【0016】一般式(1)で表される本発明の光学活性
エステル誘導体は、後記実施例に具体的に示すように、
例えば次の工程(化9参照)により製造される。The optically active ester derivative of the present invention represented by the general formula (1) is, as specifically shown in Examples described later,
For example, it is produced by the following step (see Chemical formula 9).
【0017】即ち、まず、一般式(5):That is, first, the general formula (5):
【0018】[0018]
【化5】 Embedded image
【0019】で表されるp−メトキシフェニル酢酸にオ
キシ塩化リン、ジメチルホルムアミド、次いで、過塩素
酸マグネシウムを作用させ、一般式(6):Phosphorus oxychloride, dimethylformamide, and then magnesium perchlorate are allowed to act on p-methoxyphenylacetic acid represented by the general formula (6):
【0020】[0020]
【化6】 Embedded image
【0021】で表される化合物を得る。ついで、(化
6)にp−エチルオキシカルボニルベンズアミジン塩酸
塩を塩基性条件下に作用させ、一般式(7):The compound represented by the formula is obtained. Then, p-ethyloxycarbonylbenzamidine hydrochloride is allowed to act on (Chemical Formula 6) under basic conditions to obtain a compound of the general formula (7):
【0022】[0022]
【化7】 Embedded image
【0023】で表される化合物を得る。更に、(化7)
を臭化水素水および酢酸で処理することにより、一般式
(8):The compound represented by the formula is obtained. Further,
Is treated with aqueous hydrogen bromide and acetic acid to obtain a compound of the general formula (8):
【0024】[0024]
【化8】 Embedded image
【0025】で表される化合物を得る。そして、(化
8)のヒドロキシル基を保護するが、後述の脱保護基反
応が容易なことより、アセチル基で保護するのがよく、
通常は、無水酢酸によりヒドロキシル基をアセチル化し
て、一般式(3)で表される化合物(化3)が得られ
る。The compound represented by the formula is obtained. Then, the hydroxyl group of (Chemical Formula 8) is protected, but it is better to protect it with an acetyl group because the deprotection group reaction described later is easy.
Usually, the hydroxyl group is acetylated with acetic anhydride to obtain a compound represented by the general formula (3).
【0026】このようにして得られた(化3)は、一般
式(4)で表されるの光学活性なp−ヒドロキシフェニ
ルエタノールの脂肪酸エステル(化4)と、DCC法、
酸クロライド法等の公知の方法でエステル化反応させる
ことにより一般式(2)で表される光学活性エステル誘
導体(化2)にすることができる。さらに、(化2)
は、ベンジルアミン等を作用させることにより保護基
(アセチル基)を脱離して、一般式(1)で表されるヒ
ドロキシル基を有する光学活性エステル誘導体(化1)
を得る。The thus-obtained (Chemical Formula 3) is obtained by combining the optically active fatty acid ester of p-hydroxyphenylethanol represented by the general formula (4) with the DCC method,
By performing an esterification reaction by a known method such as an acid chloride method, an optically active ester derivative (Formula 2) represented by the general formula (2) can be obtained. In addition,
Is an optically active ester derivative having a hydroxyl group represented by the general formula (1) by removing a protecting group (acetyl group) by reacting with benzylamine or the like.
Get.
【0027】[0027]
【化9】 Embedded image
【0028】上記の反応工程(化9)以外の工程とし
て、以下の工程(化15)を例示することができる。As a step other than the above reaction step (Chem. 9), the following step (Chem. 15) can be exemplified.
【0029】まず、一般式(10):First, the general formula (10):
【0030】[0030]
【化10】 Embedded image
【0031】で表される化合物にオキシ塩化リン、ジメ
チルホルムアミド、次いで、過塩素酸マグネシウムを作
用させ、一般式(11):The compound represented by the general formula (11) is reacted with phosphorus oxychloride, dimethylformamide, and then magnesium perchlorate to obtain a compound represented by the general formula (11):
【0032】[0032]
【化11】 Embedded image
【0033】で表される化合物を得る。ついで、(化1
1)にp−エチルオキシカルボニルベンズアミジン塩酸
塩を塩基性条件下に作用させ、一般式(12):The compound represented by the formula is obtained. Then, (Chemical 1
1) p-ethyloxycarbonylbenzamidine hydrochloride is allowed to act on the compound under basic conditions to obtain a compound of the general formula (12):
【0034】[0034]
【化12】 Embedded image
【0035】で表される化合物を得る。更に、(化1
2)をエタノール中、水酸化カリウムで加水分解するこ
とにより、一般式(13):The compound represented by the formula is obtained. Furthermore, (Chemical 1
2) is hydrolyzed with potassium hydroxide in ethanol to give a compound of the general formula (13):
【0036】[0036]
【化13】 Embedded image
【0037】で表される化合物を得る。そして、(化1
3)は、(化4)と、DCC法、酸クロライド法等の公
知の方法でエステル化反応させることにより、一般式
(14):The compound represented by the formula is obtained. And (Chemical 1
3) is obtained by subjecting (Chemical Formula 4) to an esterification reaction by a known method such as a DCC method or an acid chloride method to obtain a compound of the general formula (14):
【0038】[0038]
【化14】 Embedded image
【0039】で表される化合物にすることができる。最
後に、(化14)にパラジウム・カーボンを作用させる
ことにより脱保護基反応を行い、一般式(1)で表され
るヒドロキシル基を有する光学活性エステル誘導体(化
1)を得る。The compound represented by the formula: Finally, a deprotection group reaction is performed by reacting palladium / carbon on (Chem. 14) to obtain an optically active ester derivative (Chem. 1) having a hydroxyl group represented by the general formula (1).
【0040】[0040]
【化15】 Embedded image
【0041】なお、前記光学活性化合物{p−ヒドロキ
シフェニルエタノールの脂肪酸エステル、(化4)}
は、ラセミ体の1−{4−(1−エトキシエトキシ)フ
ェニル}エタノールと2,2,2,−トリクロロエタノ
ールの脂肪酸エステル(脂肪酸の炭素数2〜16)また
は、一般式(16):H2 C=CR2 OCOR1 (式
中、R1 は前記に同じ、R2 は水素原子またはメチル基
を表す)で表されるビニルエステルとを、有機溶媒中エ
ステラーゼ活性を有する酵素を用いて不斉エステル交換
した後、1−エトキシエトキシ基を除去することにより
得られる(特開平2−262536号公報参照)。The above optically active compound {fatty acid ester of p-hydroxyphenylethanol, (Chem. 4)}
Is a fatty acid ester of racemic 1- {4- (1-ethoxyethoxy) phenyl} ethanol and 2,2,2-trichloroethanol (having 2 to 16 carbon atoms in the fatty acid) or a compound represented by the general formula (16): H The vinyl ester represented by 2C = CR 2 OCOR 1 (wherein R 1 is the same as above and R 2 represents a hydrogen atom or a methyl group) cannot be synthesized using an enzyme having esterase activity in an organic solvent. It is obtained by removing the 1-ethoxyethoxy group after asymmetric transesterification (see JP-A-2-262536).
【0042】以下に、本発明を実施例をあげてさらに詳
細に説明するが、本発明はこれに限定されるものではな
い。Hereinafter, the present invention will be described in more detail with reference to examples, but the present invention is not limited thereto.
【0043】実施例1 5−(ヒドロキシフェニル)−2−〔[4´−{1´´
−(デカノイルオキシ)エチル}フェニルオキシカルボ
ニル]フェニル〕ピリミジンの合成Example 1 5- (hydroxyphenyl) -2-[[4 '-{1 ""
Synthesis of-(decanoyloxy) ethyl {phenyloxycarbonyl] phenyl] pyrimidine
【0044】(第1段) ジメチルホルムアミド81.8g(1.1ミリモル)
に、オキシ塩化リン102.6(0.67ミリモル)を
0℃で滴下し、ついでp−メトキシフェニル酢酸66g
を−10℃の温度で少しずつ加えた。混合物を20℃で
1時間、60℃で2時間、および80℃で5時間撹拌し
た。ジメチルホルムアミドを減圧留去し、残査を冷却
し、過塩素酸マグネシウムの飽和水溶液に投入した。析
出した結晶をろ別し、エ−テルで洗浄して、過塩素酸塩
61g(収率81.2%)を得た。(First stage) 81.8 g (1.1 mmol) of dimethylformamide
Then, 102.6 (0.67 mmol) of phosphorus oxychloride was added dropwise at 0 ° C., and 66 g of p-methoxyphenylacetic acid was added.
At a temperature of -10C. The mixture was stirred at 20 ° C. for 1 hour, 60 ° C. for 2 hours, and 80 ° C. for 5 hours. Dimethylformamide was distilled off under reduced pressure, and the residue was cooled and poured into a saturated aqueous solution of magnesium perchlorate. The precipitated crystals were separated by filtration and washed with ether to obtain 61 g of a perchlorate (yield: 81.2%).
【0045】この塩23.9g(72ミリモル)とp−
エトキシカルボニルベンズアミジン塩酸塩をナトリウム
エチラ−ト14.8g(0.2モル)の存在下、エタノ
−ル250ml中で8時間加熱還流した。23.9 g (72 mmol) of this salt and p-
Ethoxycarbonylbenzamidine hydrochloride was refluxed for 8 hours in 250 ml of ethanol in the presence of 14.8 g (0.2 mol) of sodium ethylate.
【0046】反応終了後、エタノ−ルを減圧留去し、酢
酸18g(0.3モル)を含む水溶液500mlを加え
撹拌した。沈澱物をろ別し、水洗、乾燥後、5−(メト
キシフェニル)−2−[4−(1−エトキシカルボニ
ル)フェニル]ピリミジン15.2g(収率63%)を
得た。After completion of the reaction, ethanol was distilled off under reduced pressure, and 500 ml of an aqueous solution containing 18 g (0.3 mol) of acetic acid was added and stirred. The precipitate was separated by filtration, washed with water and dried to obtain 15.2 g (yield 63%) of 5- (methoxyphenyl) -2- [4- (1-ethoxycarbonyl) phenyl] pyrimidine.
【0047】(第2段) 5−(メトキシフェニル)−2−[4−(1−エトキシ
カルボニル)フェニル]ピリミジン7.6g(23ミリ
モル)、臭化水素酸50g、酢酸100mlの混合物を
60時間還流した。酢酸の大部分を減圧留去したのち水
を加えた。沈澱物を充分に水洗し、乾燥して、5−(ヒ
ドロキシフェニル)−2−[4−(1−エトキシカルボ
ニル)フェニル]ピリミジン7.1g(収率99%)を
得た。(Second stage) A mixture of 7.6 g (23 mmol) of 5- (methoxyphenyl) -2- [4- (1-ethoxycarbonyl) phenyl] pyrimidine, 50 g of hydrobromic acid and 100 ml of acetic acid was used for 60 hours. Refluxed. Most of the acetic acid was distilled off under reduced pressure, and then water was added. The precipitate was sufficiently washed with water and dried to obtain 7.1 g of 5- (hydroxyphenyl) -2- [4- (1-ethoxycarbonyl) phenyl] pyrimidine (yield: 99%).
【0048】(第3段) 5−(ヒドロキシフェニル)−2−[4−(1−エトキ
シカルボニル)フェニル]ピリミジン31g(106ミ
リモル)、ピリジン310ml、無水酢酸38g(35
0ミリモル)の混合物を70℃で10時間反応させたの
ち、100mlの氷水を加えた。析出した沈澱を濾別、
水洗、乾燥後、5−(アセチルオキシフェニル)−2−
[4−(1−エトキシカルボニル)フェニル]ピリミジ
ンを32g(収率90%)を得た。得られた5−(アセ
チルオキシフェニル)−2−[4−(1−エトキシカル
ボニル)フェニル]ピリミジン32g(95ミリモル)
を塩化チオニル100ml中に懸濁し、15時間加熱還
流後、過剰の塩化チオニルを減圧留去した。酸クロライ
ドを単離することなくピリジン80mlを加え、更に
(S)−1−(p−ヒドロキシフェニル)エタノールの
デカン酸エステル35g(120ミリモル)を加え5時
間反応させた。反応混合物にクロロホルム300mlを
加え5%塩酸水溶液、水、10%炭酸ナトリウム水溶液
で洗浄後、有機層を硫酸マグネシウムで乾燥し、ベンジ
ルアミン10.4g(150ミリモル)を加えた。室温
で20時間攪拌し、脱アセトキシ化を行った。反応混合
溶媒を濃縮後、シリカゲルクロマトグラフィー(CH3
Cl:アセトン=15:1)で精製し、5−(ヒドロキ
シフェニル)−2−〔[4´−{1´´−(デカノイル
オキシ)エチル}フェニルオキシカルボニル]フェニ
ル〕ピリミジン44g(収率82%)を得た。(Third Stage) 5- (Hydroxyphenyl) -2- [4- (1-ethoxycarbonyl) phenyl] pyrimidine 31 g (106 mmol), pyridine 310 ml, acetic anhydride 38 g (35 g)
(0 mmol) was reacted at 70 ° C. for 10 hours, and 100 ml of ice water was added. The deposited precipitate is separated by filtration,
After washing with water and drying, 5- (acetyloxyphenyl) -2-
32 g (yield 90%) of [4- (1-ethoxycarbonyl) phenyl] pyrimidine was obtained. 32 g (95 mmol) of the obtained 5- (acetyloxyphenyl) -2- [4- (1-ethoxycarbonyl) phenyl] pyrimidine
Was suspended in 100 ml of thionyl chloride and heated under reflux for 15 hours, and then excess thionyl chloride was distilled off under reduced pressure. Without isolating the acid chloride, 80 ml of pyridine was added, and 35 g (120 mmol) of decanoic acid ester of (S) -1- (p-hydroxyphenyl) ethanol was further added and reacted for 5 hours. After adding 300 ml of chloroform to the reaction mixture and washing with a 5% aqueous hydrochloric acid solution, water and a 10% aqueous sodium carbonate solution, the organic layer was dried over magnesium sulfate, and 10.4 g (150 mmol) of benzylamine was added. The mixture was stirred at room temperature for 20 hours to perform deacetoxylation. After concentrating the reaction mixture, silica gel chromatography (CH 3
The mixture was purified with Cl: acetone = 15: 1) to give 44 g of 5- (hydroxyphenyl) -2-[[4 ′-{1 ″-(decanoyloxy) ethyl} phenyloxycarbonyl] phenyl] pyrimidine (yield: 82). %).
【0049】得られた5−(ヒドロキシフェニル)−2
−〔[4´−{1´´−(デカノイルオキシ)エチル}
フェニルオキシカルボニル]フェニル〕ピリミジンの比
旋光度およびNMRスペクトルの分析結果は次のとおり
であった。The obtained 5- (hydroxyphenyl) -2
-[[4 '-{1 "-(decanoyloxy) ethyl}
The analysis results of the specific rotation and NMR spectrum of phenyloxycarbonyl] phenyl] pyrimidine were as follows.
【0050】比旋光度:[α]20 D =−32.8°(c
=1.0,CHCl3 )Specific rotation: [α] 20 D = −32.8 ° (c
= 1.0, CHCl 3 )
【0051】1H−NMR(300MHz,δ値pp
m,CDCl3 ):0.85(t,3H)、1.23
(br.s,12H)、1.49(d,3H)、1.5
8(m,2H)、2.27(t,2H)、5.82
(m,1H)、6.62(br.s,2H)、6.98
(d,2H)、7.20(d,2H)、7.49(d,
2H)、7.67(d,2H)、8.14(d,2
H)、8.52(d,2H)、8.97(s,2H) 1 H-NMR (300 MHz, δ value pp
m, CDCl 3): 0.85 ( t, 3H), 1.23
(Br.s, 12H), 1.49 (d, 3H), 1.5
8 (m, 2H), 2.27 (t, 2H), 5.82
(M, 1H), 6.62 (br.s, 2H), 6.98
(D, 2H), 7.20 (d, 2H), 7.49 (d,
2H), 7.67 (d, 2H), 8.14 (d, 2
H), 8.52 (d, 2H), 8.97 (s, 2H)
【0052】実施例2 5−(ヒドロキシフェニル)−2−〔[4´−{1´´
−(ブタノイルオキシ)エチル}フェニルオキシカルボ
ニル]フェニル〕ピリミジンの合成Example 2 5- (hydroxyphenyl) -2-[[4 ′-{1 ″ ”
Synthesis of-(butanoyloxy) ethyl {phenyloxycarbonyl] phenyl] pyrimidine
【0053】(S)−1−(p−ヒドロキシフェニル)
エタノールのデカン酸エステルの代わりに(S)−1−
(p−ヒドロキシフェニル)エタノールのブタン酸エス
テルをもちること以外は実施例1と同様の操作を行い、
5−(ヒドロキシフェニル)−2−〔[4´−{1´´
−(ブタノイルオキシ)エチル}フェニルオキシカルボ
ニル]フェニル〕ピリミジン38.5g(収率84%)
を得た。(S) -1- (p-hydroxyphenyl)
Instead of decanoate of ethanol, (S) -1-
The same operation as in Example 1 was carried out except that butanoic acid ester of (p-hydroxyphenyl) ethanol was used.
5- (hydroxyphenyl) -2-[[4 ′-{1 ″ ”
-(Butanoyloxy) ethyl {phenyloxycarbonyl] phenyl] pyrimidine 38.5 g (84% yield)
I got
【0054】得られた5−(ヒドロキシフェニル)−2
−〔[4´−{1´´−(ブタノイルオキシ)エチル}
フェニルオキシカルボニル]フェニル〕ピリミジンの比
旋光度およびNMRスペクトルの分析結果は次のとおり
であった。The obtained 5- (hydroxyphenyl) -2
-[[4 '-{1 "-(butanoyloxy) ethyl}
The analysis results of the specific rotation and NMR spectrum of phenyloxycarbonyl] phenyl] pyrimidine were as follows.
【0055】比旋光度:[α]20 D =−50.7°(c
=1.0,CHCl3 )Specific rotation: [α] 20 D = −50.7 ° (c
= 1.0, CHCl 3 )
【0056】1H−NMR(300MHz,δ値pp
m,CDCl3 ):0.91(t,3H)、1.54
(d,3H)、1.62(m,2H)、2.26(t,
2H)、5.83(m,1H)、6.70(br.s,
1H)、6.98(d,2H)、7.20(d,2
H)、7.49(d,2H)、7.67(d,2H)、
8.14(d,2H)、8.52(d,2H)、8.9
7(s,2H) 1 H-NMR (300 MHz, δ value pp
m, CDCl 3 ): 0.91 (t, 3H), 1.54
(D, 3H), 1.62 (m, 2H), 2.26 (t,
2H), 5.83 (m, 1H), 6.70 (br.s,
1H), 6.98 (d, 2H), 7.20 (d, 2
H), 7.49 (d, 2H), 7.67 (d, 2H),
8.14 (d, 2H), 8.52 (d, 2H), 8.9
7 (s, 2H)
【0057】実施例3 5−(ヒドロキシフェニル)−2−〔[4´−{1´´
−(デカノイルオキシ)エチル}フェニルオキシカルボ
ニル]フェニル〕ピリミジンの合成Example 3 5- (hydroxyphenyl) -2-[[4 ′-{1 ″ ”
Synthesis of-(decanoyloxy) ethyl {phenyloxycarbonyl] phenyl] pyrimidine
【0058】(第1段) ジメチルホルムアミド81.6g(1.1ミリモル)
に、オキシ塩化リン102.6(0.67ミリモル)を
0℃で滴下し、ついでp−ベンジルオキシフェニル酢酸
66g(290ミリモル)を−10℃の温度で少しずつ
加えた。混合物を20℃で1時間、60℃で2時間、お
よび80℃で5時間撹拌した。ジメチルホルムアミドを
減圧留去し、残査を冷却し、過塩素酸マグネシウムの飽
和水溶液に投入した。析出した結晶をろ別し、エ−テル
で洗浄して、過塩素酸塩61g(収率52%)を得た。(First stage) 81.6 g (1.1 mmol) of dimethylformamide
Then, 102.6 (0.67 mmol) of phosphorus oxychloride was added dropwise at 0 ° C., and 66 g (290 mmol) of p-benzyloxyphenylacetic acid was added little by little at a temperature of −10 ° C. The mixture was stirred at 20 ° C. for 1 hour, 60 ° C. for 2 hours, and 80 ° C. for 5 hours. Dimethylformamide was distilled off under reduced pressure, and the residue was cooled and poured into a saturated aqueous solution of magnesium perchlorate. The precipitated crystals were collected by filtration and washed with ether to obtain 61 g of perchlorate (yield: 52%).
【0059】この塩23.9g(58.5ミリモル)と
p−エトキシカルボニルベンズアミジン塩酸塩をナトリ
ウムエチラ−ト14.8g(64.7ミリモル)の存在
下、エタノ−ル250ml中で8時間加熱還流した。23.9 g (58.5 mmol) of this salt and p-ethoxycarbonylbenzamidine hydrochloride were added for 8 hours in 250 ml of ethanol in the presence of 14.8 g (64.7 mmol) of sodium ethylate. Heated to reflux.
【0060】反応終了後、エタノ−ルを減圧留去し、酢
酸18g(0.3モル)を含む水溶液500mlを加え
攪拌した。沈澱物をろ別し、水洗、乾燥後、5−(ベン
ジルオキシフェニル)−2−[4−(1−エトキシカル
ボニル)フェニル]ピリミジン15.2g(収率63.
4%)を得た。After completion of the reaction, ethanol was distilled off under reduced pressure, and 500 ml of an aqueous solution containing 18 g (0.3 mol) of acetic acid was added and stirred. The precipitate was collected by filtration, washed with water and dried, and then 15.2 g of 5- (benzyloxyphenyl) -2- [4- (1-ethoxycarbonyl) phenyl] pyrimidine (yield 63.
4%).
【0061】(第2段) 5−(ベンジルオキシフェニル)−2−[4−(1−エ
トキシカルボニル)フェニル]ピリミジン7.6g(1
8.5ミリモル)、1規定水酸化カリウムを含むエタノ
ール500mlの混合物を10時間還流した。反応終了
後、エタノールの大部分を減圧留去したのち、水を加え
た。沈澱物を充分に水洗し、乾燥して5−(ベンジルオ
キシフェニル)−2−[4−(1−カルボキシ)フェニ
ル]ピリミジン15.2g(収率99%)を得た。(Second stage) 7.6 g of 5- (benzyloxyphenyl) -2- [4- (1-ethoxycarbonyl) phenyl] pyrimidine (1
(8.5 mmol) A mixture of 500 ml of ethanol containing 1 N potassium hydroxide was refluxed for 10 hours. After completion of the reaction, most of the ethanol was distilled off under reduced pressure, and then water was added. The precipitate was sufficiently washed with water and dried to obtain 15.2 g of 5- (benzyloxyphenyl) -2- [4- (1-carboxy) phenyl] pyrimidine (yield: 99%).
【0062】(第3段) 5−(ベンジルオキシフェニル)−2−[4−(1−カ
ルボキシ)フェニル]ピリミジン31g(81.2ミリ
モル)を塩化チオニル100ml中に懸濁し、15時間
加熱還流後、過剰の塩化チオニルを減圧留去した。酸ク
ロライドを単離することなくピリジン80mlを加え、
更に(S)−1−(p−ヒドロキシフェニル)エタノー
ルのデカン酸エステル35g(120ミリモル)を加え
5時間反応させた。反応混合物にクロロホルム300m
lを加え5%塩酸水溶液、水、10%炭酸ナトリウム水
溶液で洗浄後、有機層を硫酸マグネシウムで乾燥し濃縮
後、500mlのテトラヒドロフランに溶解し、5%パ
ラジウム−カーボン3gを添加し水素気流下、20時間
撹拌し、接触水添による脱ベンジル化を行った。反応混
合溶媒をろ過、濃縮後、シリカゲルクロマトグラフィー
(CH3 Cl:アセトン=15:1)で精製し、5−
(ヒドロキシフェニル)−2−〔[4´−{1´´−
(デカノイルオキシ)エチル}フェニルオキシカルボニ
ル]フェニル〕ピリミジン42.3g(収率92%)を
得た。(Third stage) 31 g (81.2 mmol) of 5- (benzyloxyphenyl) -2- [4- (1-carboxy) phenyl] pyrimidine was suspended in 100 ml of thionyl chloride, and the mixture was heated under reflux for 15 hours. The excess thionyl chloride was distilled off under reduced pressure. Add 80 ml of pyridine without isolating the acid chloride,
Further, 35 g (120 mmol) of decanoic acid ester of (S) -1- (p-hydroxyphenyl) ethanol was added, and the mixture was reacted for 5 hours. 300 m chloroform in the reaction mixture
After washing with 5% aqueous hydrochloric acid, water and 10% aqueous sodium carbonate, the organic layer was dried over magnesium sulfate, concentrated, dissolved in 500 ml of tetrahydrofuran, 3 g of 5% palladium-carbon was added, and the mixture was added under a stream of hydrogen. The mixture was stirred for 20 hours and debenzylated by catalytic hydrogenation. The reaction mixture was filtered and concentrated, and then purified by silica gel chromatography (CH 3 Cl: acetone = 15: 1).
(Hydroxyphenyl) -2-[[4 ′-{1 ″-
42.3 g (92% yield) of (decanoyloxy) ethyl {phenyloxycarbonyl] phenyl] pyrimidine were obtained.
【0063】得られた5−(ヒドロキシフェニル)−2
−〔[4´−{1´´−(デカノイルオキシ)エチル}
フェニルオキシカルボニル]フェニル〕ピリミジンの比
旋光度およびNMRスペクトルの分析結果は実施例1と
同様であった。The obtained 5- (hydroxyphenyl) -2
-[[4 '-{1 "-(decanoyloxy) ethyl}
The analysis results of the specific rotation and the NMR spectrum of phenyloxycarbonyl] phenyl] pyrimidine were the same as those in Example 1.
【0064】実施例4 5−(ヒドロキシフェニル)−2−〔[4´−{1´´
−(ブタノイルオキシ)エチル}フェニルオキシカルボ
ニル]フェニル〕ピリミジンの合成Example 4 5- (hydroxyphenyl) -2-[[4 '-{1 ""
Synthesis of-(butanoyloxy) ethyl {phenyloxycarbonyl] phenyl] pyrimidine
【0065】(S)−1−(p−ヒドロキシフェニル)
エタノールのデカン酸エステルの代わりに(S)−1−
(p−ヒドロキシフェニル)エタノールのブタン酸エス
テルをもちること以外は実施例3と同様の操作を行い、
5−(ヒドロキシフェニル)−2−〔[4´−{1´´
−(ブタノイルオキシ)エチル}フェニルオキシカルボ
ニル]フェニル〕ピリミジン34.9g(収率89%)
を得た。(S) -1- (p-hydroxyphenyl)
Instead of decanoate of ethanol, (S) -1-
The same operation as in Example 3 was carried out except that butanoic acid ester of (p-hydroxyphenyl) ethanol was used.
5- (hydroxyphenyl) -2-[[4 ′-{1 ″ ”
-(Butanoyloxy) ethyl {phenyloxycarbonyl] phenyl] pyrimidine 34.9 g (89% yield)
I got
【0065】得られた5−(ヒドロキシフェニル)−2
−〔[4´−{1´´−(ブタノイルオキシ)エチル}
フェニルオキシカルボニル]フェニル〕ピリミジンの比
旋光度およびNMRスペクトルの分析結果は実施例3と
同様であった。The obtained 5- (hydroxyphenyl) -2
-[[4 '-{1 "-(butanoyloxy) ethyl}
The analysis results of the specific rotation and NMR spectrum of phenyloxycarbonyl] phenyl] pyrimidine were the same as those in Example 3.
【0066】[0066]
【発明の効果】本発明のエステル誘導体は、液晶組成
物、とくに強誘電性液晶組成物を製造するために使用さ
れる中間体として有用である。Industrial Applicability The ester derivative of the present invention is useful as an intermediate used for producing a liquid crystal composition, particularly a ferroelectric liquid crystal composition.
───────────────────────────────────────────────────── フロントページの続き (58)調査した分野(Int.Cl.7,DB名) C07D 239/26 CA(STN) REGISTRY(STN)──────────────────────────────────────────────────続 き Continued on the front page (58) Field surveyed (Int. Cl. 7 , DB name) C07D 239/26 CA (STN) REGISTRY (STN)
Claims (3)
ルの脂肪酸エステルによりエステル化した後、脱アセト
キシ化することを特徴とする請求項1記載の光学活性化
合物の製造方法。3. A compound of the general formula (3): A compound represented by the general formula (4): 2. The method for producing an optically active compound according to claim 1, wherein the esterification is carried out by esterification with an optically active fatty acid ester of p-hydroxyphenylethanol represented by the formula:
Priority Applications (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP09296291A JP3146508B2 (en) | 1991-03-29 | 1991-03-29 | Optically active compound and method for producing the same |
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
JP09296291A JP3146508B2 (en) | 1991-03-29 | 1991-03-29 | Optically active compound and method for producing the same |
Publications (2)
Publication Number | Publication Date |
---|---|
JPH04300869A JPH04300869A (en) | 1992-10-23 |
JP3146508B2 true JP3146508B2 (en) | 2001-03-19 |
Family
ID=14069060
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
JP09296291A Expired - Fee Related JP3146508B2 (en) | 1991-03-29 | 1991-03-29 | Optically active compound and method for producing the same |
Country Status (1)
Country | Link |
---|---|
JP (1) | JP3146508B2 (en) |
Families Citing this family (2)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
DE4241806A1 (en) * | 1992-12-11 | 1994-06-16 | Hoechst Ag | New 2,5-di:aryl-pyrimidine derivs. - with nonlinear optical properties, useful e.g. for frequency doubling of light and in liq. crystal mixt. |
US5486935A (en) * | 1993-06-29 | 1996-01-23 | Kaiser Aerospace And Electronics Corporation | High efficiency chiral nematic liquid crystal rear polarizer for liquid crystal displays having a notch polarization bandwidth of 100 nm to 250 nm |
-
1991
- 1991-03-29 JP JP09296291A patent/JP3146508B2/en not_active Expired - Fee Related
Also Published As
Publication number | Publication date |
---|---|
JPH04300869A (en) | 1992-10-23 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
JP3291033B2 (en) | Optically active phenyl compound | |
JP3146508B2 (en) | Optically active compound and method for producing the same | |
US5443755A (en) | Optically active tetrahydropyrane derivatives, liquid crystal composition and liquid crystal device containing the same | |
US5164113A (en) | Optical active compound and liquid crystal composition | |
JP2971129B2 (en) | Ester derivatives | |
JPH0794446B2 (en) | 2-phenylpyrimidine derivative | |
JP3851992B2 (en) | Method for producing asymmetric azines | |
US5164112A (en) | α-hydroxyketone derivatives, liquid crystal compositions containing said derivatives, and liquid crystal devices using said compositions | |
JP2667911B2 (en) | Optically active fluorine-containing benzoic acid derivative | |
JPH04264071A (en) | Optically active compound and its production | |
US5118442A (en) | Optically active compound | |
JPH09510227A (en) | Chiral compound | |
JPH0717616B2 (en) | Pyrimidinylphenyl ester derivative | |
EP0388225A2 (en) | Optically active substance and liquid crystal composition comprising same | |
JP2700339B2 (en) | Novel ester compound and liquid crystal composition containing the same | |
JPH02129158A (en) | Optically active glycine derivative and preparation thereof | |
JP2571943B2 (en) | Benzoyloxyphenylpyrimidine derivative | |
JP2515546B2 (en) | Optically active benzoic acid compound | |
JP3020711B2 (en) | Novel phenylpyridine compound and liquid crystal composition | |
JP2821031B2 (en) | Optically active γ-lactone derivative | |
JP2763309B2 (en) | Optically active compound and method for producing the same | |
JP2869214B2 (en) | Optically active tetrahydrofuran derivative | |
JP3796761B2 (en) | Optically active compound | |
JP2828272B2 (en) | Preparation of optically active compounds | |
JP2809760B2 (en) | Optically active compound and method for producing the same |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
LAPS | Cancellation because of no payment of annual fees |